
xiii
Preface
is book looks at the Drug Quality and Security Act of 2013 and how
it will potentially impact the supply chain participants and professionals
throughout the pharmaceutical drug supply chain. Several of the provi-
sions in this act were not yet nalized by the press time of this book, but
the direction of the overall act has been set by Congress and signed into
law by the president of the United States.
My focus as a supply chain practitioner, rst within industry and later in
consulting, has always been end-to-end anchored by the patient/consumer.
Little did I know that the origins for this book would begin with me as a
consumer in ...